These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 9412209

  • 1. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM, Sanz Chinesta S, Jiménez Cruz JF, Flores Corral N, Unda Urzaiz M, Leiva Galvis O, González Romojaro V, Hernández Fernández C, Lledó García E, Rioja Sanz LA, Gonzalvo Ibarra A, Camacho González JE, Ruíz Alvárez-Cienfuegos F, Resel Estévez L, Corral Saleta J, Burgos Rodríguez R, Del Rosal Samaniego JM.
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [Abstract] [Full Text] [Related]

  • 2. [Cost-effectiveness analysis of ceftriaxone and cefotaxime in the treatment of community-acquired pneumonia].
    García-Contreras F, Del-Angel-García G, Ramírez Cuenca A, Malváez-Valdes M, Vega Yáñez A, Amato D.
    Rev Invest Clin; 2000; 52(4):418-26. PubMed ID: 11061104
    [Abstract] [Full Text] [Related]

  • 3. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B, Hu J, Deng W.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [Abstract] [Full Text] [Related]

  • 4. Ceftriaxone is twice as cost-effective as standard therapy in biliary tract infection.
    Zoepf T, Jakobs R, Riemann JF.
    Hepatogastroenterology; 2004 Sep; 51(58):941-5. PubMed ID: 15239219
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
    Parrish AG.
    S Afr Med J; 1998 Sep; 88(9):1046, 1048; author reply 1050-1. PubMed ID: 9798485
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG, Woods GL, Jiang Q, Gesser RM.
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [Abstract] [Full Text] [Related]

  • 7. Ceftriaxone for once-a-day therapy of urinary tract infections.
    Childs SJ, Wells WG, Mirelman S.
    Am J Med; 1984 Oct 19; 77(4C):73-6. PubMed ID: 6093524
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
    Wessels F, Anderson AN, Ebrahim O.
    S Afr Med J; 1998 Mar 19; 88(3):251-5. PubMed ID: 9608289
    [Abstract] [Full Text] [Related]

  • 9. [Cefminox versus cefotaxime in the treatment of complicated urinary tract infection].
    Gastón de Iriarte E, Cárcamo Valor P, Diez-Enciso M, Prieto Prieto J, Pérez Balcabao I, Gimeno del Sol M, Coronel Granado P, Morán Soto MJ.
    Actas Urol Esp; 1995 Sep 19; 19(8):635-41. PubMed ID: 8669331
    [Abstract] [Full Text] [Related]

  • 10. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL, Foster RH, Benfield P.
    Pharmacoeconomics; 1998 Jan 19; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic exchange of cefotaxime for ceftriaxone: evaluation, implementation, and subsequent cost savings at a 300-bed community hospital.
    Rawlings RD.
    Diagn Microbiol Infect Dis; 1995 Jan 19; 22(1-2):235-7. PubMed ID: 7587046
    [Abstract] [Full Text] [Related]

  • 12. Comparison of ceftriaxone versus cefotaxime for childhood upper urinary tract infections.
    Bakkaloglu A, Saatci U, Soylemezoglu O, Ozen S, Topaloglu R, Besbas N, Saatci I.
    J Chemother; 1996 Feb 19; 8(1):59-62. PubMed ID: 8835111
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The effect of a rational and consensual protocol for the use of ceftriaxone in a general hospital].
    Gómez Vargas J, Gómez J, Ruiz Gómez J, Simarro E, San Miguel T, Canteras M, Valdés M.
    Rev Esp Quimioter; 1998 Dec 19; 11(4):327-32. PubMed ID: 9990146
    [Abstract] [Full Text] [Related]

  • 16. Cefotaxime and cefazolin in the treatment of complicated urinary tract infections: a comparative study.
    Madsen PO, Iversen P.
    Clin Ther; 1981 Dec 19; 4(1):7-11. PubMed ID: 6268298
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S.
    Minerva Pediatr; 2003 Oct 19; 55(5):395-406. PubMed ID: 14608263
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical studies on ceftriaxone in complicated urinary tract infections].
    Yamakawa K, Hioki T, Kawamura J.
    Hinyokika Kiyo; 1989 Feb 19; 35(2):377-82. PubMed ID: 2735247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.